MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/irv.70198

Медицинская библиотека · Influenza and other respiratory viruses · 2025

Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study.

Humphreys James, Nicolay Nathalie, Braeye Toon, Van Evercooren Izaak, Hansen Christian Holm, Moustsen-Helms Ida Rask, Sacco Chiara, Fabiani Massimo, Castilla Jesús, Martínez-Baz Iván, Machado Ausenda, Soares Patricia, Ljung Rickard, Pihlström Nicklas, Kissling Esther, Nardone Anthony, Monge Susana, Bacci Sabrina, Nunes Baltazar, VEBIS‐EHR working group

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

After a period of low SARS-CoV-2 activity, viral circulation increased in Europe from May 2024, driven by immune-evasive KP sublineages of the JN.1 variant. We estimated vaccine effectiveness (VE) of the XBB.1.5 dose administered in autumn 2023 against COVID-19-related hospitalisations and deaths in individuals 65 years of age or older during this period.

METHODS

We conducted a multi-country cohort study across six EU nations in the VEBIS-EHR network using linked electronic health records. VE against COVID-19-related hospitalisation and death during June-August 2024 was estimated using Cox regression in a two-stage analysis, adjusting for demographics, comorbidities and prior vaccination history.

RESULTS

Among individuals 65-79 and ≥ 80 years old, respectively, VE of the XBB.1.5 dose ≥ 6 months post administration was 13% (95% CI: -12% to 33%) and 7% (95% CI: -7% to 19%) against hospitalisation and 39% (95% CI: -7% to 65%) and 3% (95% CI: -23% to 23%) against deaths.

CONCLUSIONS

XBB.1.5 vaccination provided minimal residual protection against severe COVID-19 outcomes among adults aged ≥ 65 years more than 6 months after vaccination, during the summer 2024 period of increased SARS-CoV-2 activity.

Для цитирования: Humphreys James, Nicolay Nathalie, Braeye Toon, Van Evercooren Izaak, Hansen Christian Holm, Moustsen-Helms Ida Rask, Sacco Chiara, Fabiani Massimo, Castilla Jesús, Martínez-Baz Iván, Machado Ausenda, Soares Patricia, Ljung Rickard, Pihlström Nicklas, Kissling Esther, Nardone Anthony, Monge Susana, Bacci Sabrina, Nunes Baltazar, VEBIS‐EHR working group. Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study.. Influenza and other respiratory viruses. 2025. DOI: 10.1111/irv.70198.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.